BladerJC, PliszkaSR, KafantarisV, et al.Stepped Treatment for Attention-Deficit/hyperactivity disorder and aggressive behavior: A randomized, controlled trial of adjunctive risperidone, divalproex sodium, or placebo after stimulant medication optimization. J Am Acad Child Adolesc Psychiatry2021;60(2):236–251.
2.
HiltRJ. Editorial: Best practices in child antipsychotic use monitoring. J Am Acad Child Adolesc Psychiatry2021;60(1):24–25.
3.
LandauZ, Pinhas-HamielO. Attention deficit/hyperactivity, the metabolic syndrome, and type 2 diabetes. Curr Diab Rep2019;19(8):46.
4.
PliszkaSR, CrismonML, HughesCW, TEXAS CONSENSUS CONFERENCE PANEL ON PHARMACOTHERAPY OF CHILDHOOD ATTENTION DEFICIT HYPERACTIVITY DISORDER. et al.; The Texas Children’s Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry2006;45(6):642–657.
5.
ZhuY, ZitoJM, GardnerJF, et al.Stimulants Concomitant with other psychotropic classes: A competing risk analysis in medicaid-insured youth. J Child Adolesc Psychopharmacol2025;35(5):277–284.
